"Epitope Mapping" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods used for studying the interactions of antibodies with specific regions of protein antigens. Important applications of epitope mapping are found within the area of immunochemistry.
| Descriptor ID |
D018604
|
| MeSH Number(s) |
E05.478.274 E05.601.690.300
|
| Concept/Terms |
Epitope Mapping- Epitope Mapping
- Epitope Mappings
- Mapping, Epitope
- Mappings, Epitope
|
Below are MeSH descriptors whose meaning is more general than "Epitope Mapping".
Below are MeSH descriptors whose meaning is more specific than "Epitope Mapping".
This graph shows the total number of publications written about "Epitope Mapping" by people in this website by year, and whether "Epitope Mapping" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 6 | 7 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 3 | 3 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 5 | 5 |
| 2005 | 1 | 4 | 5 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 2 | 3 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 5 | 5 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 3 | 4 |
| 2014 | 1 | 2 | 3 |
| 2015 | 0 | 2 | 2 |
| 2016 | 0 | 5 | 5 |
| 2017 | 1 | 3 | 4 |
| 2018 | 0 | 6 | 6 |
| 2020 | 1 | 4 | 5 |
| 2021 | 1 | 5 | 6 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Epitope Mapping" by people in Profiles.
-
Computational epitope mapping of class I fusion proteins using low complexity supervised learning methods. PLoS Comput Biol. 2022 12; 18(12):e1010230.
-
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study. Science. 2021 Oct 22; 374(6566):472-478.
-
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition. Cell Rep. 2021 10 05; 37(1):109784.
-
Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope. Cell. 2021 08 19; 184(17):4414-4429.e19.
-
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress. Cell. 2021 08 19; 184(17):4430-4446.e22.
-
Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses. Nat Commun. 2021 07 14; 12(1):4320.
-
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions. Cell Rep Med. 2021 06 15; 2(6):100313.
-
Global analysis of shared T?cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021 03 09; 54(3):586-602.e8.
-
Accurate determination of epitope for antibodies with unknown 3D structures. MAbs. 2021 Jan-Dec; 13(1):1961349.
-
High-Resolution Mapping of Human Norovirus Antigens via Genomic Phage Display Library Selections and Deep Sequencing. J Virol. 2020 12 09; 95(1).